About this event

  • Date and time Mon 25 Nov 2019 from 8:00am to 6:00pm
  • Location Royal Society of Medicine
  • Organised by Oncology

Join us for the 4th year of this important conference, where international leaders in the field will discuss the importance of effective cancer control in low and middle-income countries (LMIC) and highlight the magnitude of the disparities and issues that currently exist. 


This event is part of the inaugural London Global Cancer Week - a series of coordinated international discussions and events that provides a comprehensive image of the growing incidence of cancer worldwide, encourages countries to prioritise cancer control services in their health strategies, and discusses how the UK can contribute towards building capacity for sustainable cancer control in developing countries through training, research, aid, and diplomacy. 

At the RSM meeting, first-hand accounts of healthcare professionals working in low and middle income countries will share experiences to increase awareness on global cancer collaborations that currently exist, improve understanding of the challenges to delivering cancer care, and provide a forum to discuss future strategies to improve global cancer control. We are delighted to announce that the London Global Cancer Week launch lecture will be given by HRH Princess Dina Mired of Jordan who will speak about the need for a new paradigm shift on building sustainable partnerships and solutions to tackle cancer control challenges in the LMIC.

Topics include:

- Build collaborative networks between LMIC, UK and globally
- Address the global disparity in cancer care through collaborative networks
- Promote learning and sharing through practice and data-sharing across the globe
- Advocate for improvement in global cancer control and learn how to become further involved in this field
- Provide an opportunity for attendees to showcase their work in this field

Key international healthcare organisations including THET and Kings Health Partners will be represented. 

Can't make it to London for this event? You can now live stream this meeting from anywhere. All's you need is a good internet connection. Click here to book for the live stream. 

Join in the conversation online using #RSMCancerLMIC #LondonGlobalCancer
Follow us on Twitter: @RoySocMed and @LGCW2019


We would like to thank our exhibitors MSD (and others), for providing sponsorship towards this meeting

Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Key speakers

HRH Princess Dina Mired of Jordan

HRH Princess Dina Mired

President, Union of International Cancer Control (UICC)

Speaker's biography

HRH Princess Dina Mired is a well-known passionate global advocate for cancer control and non-communicable diseases and mother of a cancer survivor.

HRH Princess Dina was elected as president of UICC In November 2018. Testament to her outstanding leadership, she was the first Arab to have been elected in such a prestigious global post.

On September of 2011 Princess Dina delivered the keynote speech on behalf of all civil society on the opening of the United Nations General Assembly first ever high-level meeting on non-communicable disease’s (NCDs). On September of 2018 Princess Dina was chosen again to speak at the third high level meeting on NCDs as “eminent champion of the fight against non-communicable diseases”.

As director general of the King Hussein Cancer Foundation (KHCF) in Jordan 2002 - 2016, Princess Dina established and led KHCF in Jordan for fifteen years transforming the non-profit into the most successful fundraiser for cancer control efforts in Jordan and an internationally known brand.

Princess Dina was the honorary chairperson of the Jordan Breast Cancer Program as founder from 2006 to 2016. Princess Dina is also a well-known fierce global advocate in the fight against tobacco.

Princess Dina serves in many high-profile international positions such as being an honorary ambassador of Harvard Global Health Win – Win Initiative and is recipient of many awards including the prestigious “International Agency for Research on Cancer (IARC) Medal of Honour, “Personality of the year 2016 in the fight against breast cancer”, Female of the year 2017- Golden Award for Excellence” by the Arab Women Council. Arab Woman Award 2018 for “Achievements in Global Leadership in Cancer Control”.

Professor Richard Sullivan

Professor Richard Sullivan

Chair, Cancer and Global Health, King’s College London and Guy's and St Thomas' NHS Foundation Trust

Speaker's biography

Professor Richard Sullivan is professor of cancer and global health at King’s College London, and director of the King’s Institute of Cancer Policy and co-director of the Conflict and Health Research Group. As well as holding a number of visiting chairs, Professor Richard Sullivan is an non-communicable disease (NCD) advisor to the World Health Organization (WHO), civil-military advisor to Save the Children, and a member of the National Cancer Grid of India.

His research focuses on global cancer policy and planning, and health systems strengthening, particularly fragile and conflict settings. Professor Richard Sullivan’s research teams have programs in capacity building in conflict and health across the Middle East and North Africa (r4hc-mena.org), as well as programmes in women’s health, digital innovation (VR enhanced surgery) and a wide range of global health security projects. Professor Sullivan qualified in medicine and trained in surgery (urology), gaining his PhD in biochemistry from University College London. As well as working as research and development lead in industry he was also clinical director of Cancer Research UK, one of the world’s largest research funders between 1999 and 2008.

Dr Ophira Ginsburg

Dr Ophira Ginsburg

Director Perlmutter Cancer Center High Risk Program, New York University, New York, US

Speaker's biography

Dr Ophira Ginsburg is a medical oncologist and global women’s health researcher with technical and policy expertise in noncommunicable diseases prevention and management.  She is the director of the high-risk cancer genetics program and associate professor in the section for global health, department of population health at New York University School of Medicine. Formerly based at the University of Toronto, from 2015 to 2016 she was a medical officer at WHO and continues to serve as a consultant to several UN agencies, providing technical assistance to member states on national cancer control planning and policies.

Over the last 15 years, Dr Ophira Ginsburg developed an inter-disciplinary collaborative program of research, education, and policy guidance in cancer control, with colleagues on five continents. The overarching aim of her work is to improve equitable access to early detection for breast and cervical cancer in low-income and middle-income countries. She also conducts public health research to reduce cancer disparities for women in underserved communities in North America, and is leading a new study funded by the U.S. National Institutes of Health (“Cancer Moonshot” program), to improve access to cancer genetics services through primary care clinics in the New York area.

Dr Gilberto Lopes

Dr Gilberto Lopes

Associate Professor of Clinical Medicine, Sylvester Comprehensive Cancer Center and Editor in Chief, Journal of Global Oncology, American Society of Clinical Oncology

Speaker's biography

Dr Gilberto Lopes is an expert in medical oncology in low- and middle-income countries, is medical director for International programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor at the University of Miami Miller School of Medicine. He is also an associate editor for ASCO University and for ASCO’s Journal of Global Oncology. From 2006 to 2013, Dr Lopes worked for the Johns Hopkins University Singapore International Medical Center, and, prior to that, was the chief medical and scientific officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

Dr Lopes has published widely, with more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, The Lancet, The Lancet Oncology, and Nature Reviews, and has lectured nationally and internationally. He has been principal or co-principal investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary, and thoracic cancers. His areas of research interest extend to health economics, value, policy, and access to cancer drugs and treatment in low- and middle-income countries. He has served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization.

After graduating from medical school in Brazil, Dr Lopes received residency training in internal medicine and completed a fellowship in hematology and oncology at the University of Miami.


View the programme

Registration, tea and coffee
Welcome and introduction

Dr Susannah Stanway, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

Session One

Chair: Professor David Collingridge, Editor-in-Chief, The Lancet Oncology and Professor Diana Sarfati, Head of Department, Department of Public Health, University of Otago

The promise of Universal Health Coverage (UHC) for global cancer: moving from challenges to solutions

Professor Richard Sullivan, Chair, Cancer and Global Health, King’s College London and Guy's and St Thomas' NHS Foundation Trust

The challenges of substandard and falsified medicines

Ms Chloe Tuck, International Projects Lead, Commonwealth Pharmacists Association and PhD Candidate, School of Health and Related Research, University of Sheffield and Ms Oksana Pyzik, Senior Teaching Fellow and Global Engagement Lead, University College London (UCL), School of Pharmacy

Digital health in LMICs

Professor Shafi Ahmed, Surgeon, St Bartholomew's Hospital, Barts Health NHS Trust and The Royal London Hospital

Why an understanding of anthropology is so important for cancer control

Dr Carlo Caduff, Reader in Global Health and Social Medicine, King’s College London

Panel discussion
Tea and coffee break

Poster viewing

The Vanessa Moss Prize


Dr Susie Stanway

Vanessa Moss prize winner’s presentation

8 minute presentation + 2 minutes for questions

Presentation of certificate and prize for presenter

HRH Princess Dina Mired, President, Union for International Cancer Control

Health partnerships in an era of SDGs

Mr Ben Simms, Chief Executive Officer, Tropical Health and Education Trust  (THET), London

A breast cancer control strategy in Ghana: The Breast Care International (BCI) approach

Mrs Beatrice Wiafe Addai, Breast Surgeon, President, Breast Care International and CEO, Peace and Love Hospitals, Ghana

The importance of engaging with decision makers

Professor Diana Sarfati

Panel discussion

Launch of London Global Cancer Week

The need for new paradigm shift on building sustainable partnerships and solutions to tackle cancer control challenges in the LMIC

HRH Princess Dina Mired


Poster viewing

Workshops highlighting global cancer collaboration


Dr Nazima Dharsee, Consultant Clinical Oncologist, Ocean Road Cancer Institute, Dar es Salaam, Tanzania, Ms Beatrice Wiafe Addai, Professor Groesbeck Parham, Professor, Gynecologic Oncology, University of North Carolina at Chapel Hill and University of Zambia, Dr Ajay Aggarwal, Consultant Clinical Oncologist, Guy's Cancer - Guy's and St Thomas' NHS Foundation Trust and Dr Warren Phipps, Medical Director, Uganda Cancer Institute and Fred Hutchinson Centre Cancer Alliance, USA



Dr C.S. Pramesh, Director, Tata Memorial Hospital, Mumbai, India, Dr Bhawna Sirohi, Director, Medical Oncology, Max Institute of Cancer Care, New Delhi, Professor Shailesh V. Shrikhande, Deputy Director and Head of Cancer Surgery, Tata Memorial Centre, Mumbai, India

Session Two

Chairs: Professor Ophira Ginsburg, Professor of Medical Oncology, New York University, USA

Development of resource stratified oncology guidelines

Professor Ben Anderson, Professor of Surgery, University of Washington, Department of Global Health, USA

Setting up a global oncology programme

Professor Gilberto Lopes, Medical Oncologist, Sylvester Cancer Center, Miami, USA

The role of primary care in global oncology

Professor Ophira Ginsburg

Panel discussion
Tea and coffee break

Poster viewing

Challenges and opportunities in developing a cancer centre in an LMIC

Professor Shailesh V. Shrikhande

Understanding breast cancer survivorship in Tanzania

Dr Nazima Dharsee and Professor Theresa Wiseman, Lead for Health Services Research, The Royal Marsden NHS Foundation Trust

Closing remarks
Close of meeting

Drinks reception


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Other events

MGN01 Promo

Direct-to-consumer genetic testing: Health and ancestry

This event will give you a comprehensive view of the direct to consumer genetic tests available and their implications. Through lectures from renowned specialists as well as lively debates, you will be well informed of the benefits and risks of ancestry and health tests.

  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom